ACV meeting #20, 14 April 2021

The meeting of the Advisory Committee on Vaccines (ACV).

The committee provided advice on two matters relating to pharmacovigilance.

• COVID-19 Vaccine AstraZeneca and potential risk of thrombosis

• Anaphylaxis and COVID-19 Vaccines

Members

Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.